Edward McClain IV [suffix]

Mr. Edward McClain IV [suffix]

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 June 2024 in Bioengineering
Verified
Journal Article
Open access
PDF file
CCCooper Thomas Cheng
Cooper Thomas Cheng
PVPraveer Vyas
Praveer Vyas
E[Edward McClain IV [suffix]
Edward McClain IV [suffix]
THThomay Hoelen
Thomay Hoelen
CAChris Arts
Chris Arts
BCBoyle C. Cheng
Boyle C. Cheng
Bone regeneration is a complex multicellular process involving the recruitment and attachment of osteoprogenitors and their subsequent differentiation into osteoblasts that deposit extracellular matrixes. There is a growing demand for synthetic bone graft materials that can be used to augment these processes to enhance the healing of bone defects resulting from trauma, disease or surgery. P-15 is a small synthetic peptide that is identical in sequence to the cell-binding domain of type I collagen and has been extensively demonstrated in vitro and in vivo to enhance the adhesion, differentiation and proliferation of stem cells involved in bone formation. These events can be categorized into three phases: attachment, activation and amplification. This narrative review summarizes the large body of preclinical research on P-15 in terms of these phases to describe the mechanism of action by which P-15 improves bone formation. Knowledge of this mechanism of action will help to inform the use of P-15 in clinical practice as well as the development of methods of delivering P-15 that optimize clinical outcomes.

11 July 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
ATAmol H Trivedi
Amol H Trivedi
VWVicki Z. Wang
Vicki Z. Wang
E[Edward McClain IV [suffix]
Edward McClain IV [suffix]
PVPraveer Vyas
Praveer Vyas
ISIsaac Swink
Isaac Swink
PDPatrick J. DeMeo
Patrick J. DeMeo
Musculoskeletal (MSK) pathology encompasses an array of conditions that can cause anything from mild discomfort to permanent injury. Their prevalence and impact on disability have sparked interest in more effective treatments, particularly within orthopedics. As a result, the human placenta has come into focus within regenerative medicine as a perinatal derivative (PnD). These biologics are sourced from components of the placenta, each possessing a unique composition of collagens, proteins, and factors believed to aid in healing and regeneration. This review aims to explore the current literature on PnD biologics and their potential benefits for treating various MSK pathologies. We delve into different types of PnDs and their healing effects on muscles, tendons, bones, cartilage, ligaments, and nerves. Our discussions highlight the crucial role of immune modulation in the healing process for each condition. PnDs have been observed to influence the balance between anti- and pro-inflammatory factors and, in some cases, act as biologic scaffolds for tissue growth. Additionally, we assess the range of PnDs available, while also addressing gaps in our understanding, particularly regarding biologic processing methods. Although certain PnD biologics have varying levels of support in orthopedic literature, further clinical investigations are necessary to fully evaluate their impact on human patients.

6 September 2024 in Bioengineering
Verified
Journal Article
Open access
PDF file
BCBoyle C. Cheng
Boyle C. Cheng
ISIsaac Swink
Isaac Swink
CCCooper Thomas Cheng
Cooper Thomas Cheng
OCOwen G. Corcoran
Owen G. Corcoran
VWVicki Z. Wang
Vicki Z. Wang
AYAlexander Yu
Alexander Yu
P-15 is a 15-amino-acid-long biomimetic peptide widely demonstrated to enhance osteogenesis in vivo. Despite the prevalence of polyether-ether-ketone (PEEK) in interbody device manufacturing, a growing body of evidence suggests it may produce an unfavorable immune response. The purpose of this preliminary study was to characterize the immune response and new bone growth surrounding PEEK implants with and without a P-15 peptide-based osteobiologic. A bilateral femoral defect model was conducted using New Zealand white rabbits. A total of 17 test subjects received one implant in each distal femur, either with or without bone graft material. Animals were allowed to survive to 4 or 8 weeks, at which time the femurs were collected and subjected to micro-computer tomography (microCT) or cytokine analysis. MicroCT analysis included the quantification of bone growth and density surrounding each implant. The cytokine analysis of periprosthetic tissue homogenates included the quantification of interleukins (ILs) and TNF-α expression via ELISA kits. Improvements in bone volume were observed in the P-15 cohort for the regions of interest, 500–136 and 136–0 µm from the implant surface, at 8 weeks post-op. Concentrations of IL-1β, IL-4, and IL-6 cytokines were significantly higher in the P-15 cohort compared to the PEEK cohort at the 4-week timepoint. Significant reductions in the concentrations of IL-4 and IL-6 cytokines from the 4- to 8-week cohort were observed in the P-15 cohort only. The P-15 peptide has the potential to modulate the immune response to implanted materials. We observed improvements in bone growth and a more active micro-environment in the P-15 cohort relative to the PEEK control. This may indicate an earlier transition from the inflammatory to remodeling phase of healing.

14 October 2024 in European Spine Journal
Verified
Journal Article
Closed access
PDF file
E[Edward McClain IV [suffix]
Edward McClain IV [suffix]
BGBhavika Gupta
Bhavika Gupta
LZLauren Zane
Lauren Zane
JDJoel DeFelice
Joel DeFelice
CWCody Woodhouse
Cody Woodhouse
AYAlexander Yu
Alexander Yu